VANCOUVER, BC -- (MARKET WIRE) -- May 14, 2007 -- Upstream Biosciences Inc. (OTCBB: UPBS) ("Upstream" or "the Company"), an emerging leader in the field of genetic diagnostics for cancer and the prediction of drug response, has announced today the appointment of Mr. Edward Kiruluta to its scientific advisory board. Mr. Kiruluta is currently Vice President, Engineering at DemandTec, where he leads the econometrics, optimization research and database teams, and prior to joining DemandTec, Mr. Kiruluta was Senior Director of Informatics at Merck Research Labs (MRL), where he led the development of the Target Genome Index (TGI), an environment to help researchers gain better insights into biological function and drug response by integrating clinical data with genomics, proteomics and metabolomics technologies.
